RE-BVS – Piemonte Repository

Sfoglia per AUTORE
COSSU MV
Collezione ASL Città di Torino

Items : 7

Effectiveness and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide therapy in an observational Italian cohort: The DIAMANTE study in Future Virology

2023
ASL Città di Torino

Antinori A; Vergori A; Ripamonti D; Valenti D; Rizzardini G; Cossu MV; Rusconi S; Esposito V; Cascio A; Orofino G; Andreoni M; Manzillo E; Castagna A; Mancusi D; Termini R; Portaro M; Uglietti A;

Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. in The patient / Patient. 2020 Jun;13(3):375-387. doi: 10.1007/s40271-020-00413-y.

2020
ASL Città di Torino

Squillace N; Di Cristo V; Mancusi D; Scerbo P; Gori A; Rucci F; Termini R; Uglietti A; Rossetti B; Pontali E; D'Ettore G; Madeddu G; Locatelli ME; Ferrara S; Aprea L; Orofino G; Valenti D; Castagna A; Cattelan A; Focà E; Sterrantino G; Menzaghi B; Antinori A; Cossu MV;

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331.

2020
ASL Città di Torino

Sterrantino G; Menzaghi B; Cossu MV; Vergori A; Antinori A; Gori A; Rusconi S; Cattelan AM; Castelli F; Gianotti N; Orofino G; Ripamonti D; Savinelli S; Manzillo E; Santantonio TA; Celesia BM; Cauda R; Maserati R; d'Arminio Monforte A; Stingone C; Bonora S; Uglietti A; Termini R; Rucci F; Mancusi D;

Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. in The patient / Patient. 2020 Aug;13(4):469-470. doi: 10.1007/s40271-020-00425-8.

2020
ASL Città di Torino

Gori A; Rucci F; Uglietti A; Termini R; Rossetti B; Scerbo P; Pontali E; Madeddu G; Locatelli ME; Ferrara S; Aprea L; D'Ettore G; Valenti D; Orofino G; Castagna A; Focà E; Cattelan A; Di Cristo V; Squillace N; Sterrantino G; Cossu MV; Menzaghi B; Antinori A; Mancusi D;

Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio? in AIDS (London, England) / AIDS. 2018 May 15;32(8):1083-1084. doi: 10.1097/QAD.0000000000001784.

2018
ASL Città di Torino

Capetti AF; Orofino G; Paladini L; Sterrantino G; DiGiambenedetto S; De Socio GV; Cenderello G; Cossu MV; Rizzardini G;

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data. in The Annals of pharmacotherapy / Ann Pharmacother. 2018 Aug;52(8):740-746. doi: 10.1177/1060028018761600. Epub 2018 Feb 26.

2018
ASL Città di Torino

Capetti AF; Cossu MV; Sterrantino G; Barbarini G; Di Giambenedetto S; De Socio GV; Orofino G; Di Biagio A; Celesia BM; Rusconi S; Argenteri B; Rizzardini G;

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data. in BMC infectious diseases / BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.

2017
ASL Città di Torino

Capetti AF; Cossu MV; Orofino G; Sterrantino G; Cenderello G; De Socio GV; Cattelan AM; Soria A; Rusconi S; Riccardi N; Baldin GM; Niero FP; Barbarini G; Rizzardini G;